Phathom Pharmaceuticals Inc (NASDAQ: PHAT): Stock That Needs Special Handling
Currently, there are 69.64M common shares owned by the public and among those 37.92M shares have been available to trade. The company’s stock has a 5-day price change of 109.88% and 76.28% over the past three months. PHAT shares are trading 9.85% year to date (YTD), with the 12-month market performance down to -13.90% lower. […]
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) Not A Good Play Anymore?
Phathom Pharmaceuticals Inc (PHAT) concluded trading on Thursday at a closing price of $3.36, with 5.5 million shares of worth about $18.48 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -80.67% during that period and on May 01, 2025 the price saw a […]